Insulin aspart
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
<StructureSection load='' size='340' side='right' caption='PDB ID [[4gbc]]' scene='96/968809/Cv/1'> | <StructureSection load='' size='340' side='right' caption='PDB ID [[4gbc]]' scene='96/968809/Cv/1'> | ||
| - | Insulin aspart, sold under the brand name NovoLog and Fiasp, among others, is a modified type of medical insulin used to treat type 1 and type 2 diabetes. See also [https://en.wikipedia.org/wiki/Insulin_aspart]. | + | Insulin aspart, sold under the brand name NovoLog and Fiasp, among others, is a modified type of medical insulin used to treat type 1 and type 2 diabetes. See also [https://en.wikipedia.org/wiki/Insulin_aspart]. <scene name='96/968809/Test/1'>TextToBeDisplayed</scene> |
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 12:02, 6 June 2023
| |||||||||||
